Born 1977.
Jonas Faijerson Säljö has a research background in the stroke area with wide-ranging experience in the commercialization of medical innovations. Faijerson Säljö has significant expertise in intellectual property and business development experience from a large number of companies in the life science area. He is currently employed as Senior IP Business Consultant and CEO of Synergon AB.
Jonas Faijerson Säljö holds a Ph.D. in Neurobiology and is a licensed pharmacist from the University of Gothenburg.
Member of the board of Synergon AB and Innovaurum AB.
CEO of Synergon AB and founder of Innovaurum AB.
Jonas Faijerson Säljö is dependent of the company, the company management and independent of major shareholders as defined by the Swedish Code of Corporate Governance.